Cargando…
Probing Resistance Mutations in Retroviral Integrases by Direct Measurement of Dolutegravir Fluorescence
FDA-approved integrase strand transfer inhibitors (raltegravir, elvitegravir and dolutegravir) efficiently inhibit HIV-1 replication. Here, we present fluorescence properties of these inhibitors. Dolutegravir displays an excitation mode particularly dependent on Mg(2+) chelation, allowing to directl...
Autores principales: | Thierry, Eloïse, Lebourgeois, Samuel, Simon, Françoise, Delelis, Olivier, Deprez, Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5656594/ https://www.ncbi.nlm.nih.gov/pubmed/29070877 http://dx.doi.org/10.1038/s41598-017-14564-w |
Ejemplares similares
-
Different Pathways Leading to Integrase Inhibitors Resistance
por: Thierry, Eloïse, et al.
Publicado: (2017) -
Efficient and Specific Internal Cleavage of a Retroviral Palindromic DNA Sequence by Tetrameric HIV-1 Integrase
por: Delelis, Olivier, et al.
Publicado: (2007) -
Integrase and integration: biochemical activities of HIV-1 integrase
por: Delelis, Olivier, et al.
Publicado: (2008) -
Integrase inhibitor reversal dynamics indicate unintegrated HIV-1 dna initiate de novo integration
por: Thierry, Sylvain, et al.
Publicado: (2015) -
The G140S mutation in HIV integrases from raltegravir-resistant patients rescues catalytic defect due to the resistance Q148H mutation
por: Delelis, Olivier, et al.
Publicado: (2009)